1 | 10-MG dose OF E5501 2G tablet | - | - | - | - | 1件: 63 63 💬
|
2 | 10-MG dose OF E5501 cyclodextrin oral solution | - | - | - | - | 1件: 63 63 💬
|
3 | 10-MG dose OF E5501 lipid-based oral | - | - | - | - | 1件: 63 63 💬
|
4 | 10-MG dose OF E5501-P21% powder | - | - | - | - | 1件: 63 63 💬
|
5 | Acetominophen | - | - | - | - | 1件: 63 63 💬
|
6 | AKR-501, YM-477 | - | - | - | - | 1件: 63 63 💬
|
7 | Alemtuzumab, rituximab | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 63 63 💬
|
8 | ALL-trans-retinoid acid | - | - | - | - | 1件: 63 63 💬
|
9 | AMG 531 | - | - | - | - | 1件: 63 63 💬
|
10 | AMG531 | - | - | - | - | 2件: 60 60, 63 💬
|
11 | Amifostine | 1件: Amifostine Amifostine | 1件: Amifostine
Amifostine
💬
| - | - | 1件: 63 63 💬
|
12 | Aminophylline | 1件: Aminophylline Aminophylline | 2件: Aminophylline
Aminophylline
,
Aminophylline dihydrate
💬
| 18件: ADORA1 ADORA1, ADORA2B, PDE1, PDE1, PDE1, PDE10, PDE11, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE7, PDE7, PDE8, PDE8 💬
| 23件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 63 63 💬
|
13 | Amoxicillin | 2件: Amoxicillin Amoxicillin, Clavulanic acid | 5件: Amoxicillin
Amoxicillin
,
Clavulanate potassium
,
Amoxicillin sodium
,
Amoxicillin
,
Clavulanic acid
💬
| - | - | 5件: 46 46, 63, 96, 97, 299 💬
|
14 | Amoxicillin hydrate | 1件: Amoxicillin Amoxicillin | 3件: Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | 1件: 63 63 💬
|
15 | ANTI-CD38 antibody injection | - | - | - | - | 2件: 61 61, 63 💬
|
16 | ANTI-CD40L | 1件: Toralizumab Toralizumab | 1件: Toralizumab
Toralizumab
💬
| 1件: TNFSF5 TNFSF5 💬
| 14件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬 | 1件: 63 63 💬
|
17 | ANTI-CD40ldab | - | - | - | - | 1件: 63 63 💬
|
18 | ANTI-D | - | - | - | - | 1件: 63 63 💬
|
19 | ARGX-113 | - | - | - | - | 5件: 11 11, 14, 35, 53, 63 💬
|
20 | Atorvastatin 10MG | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 63 63 💬
|
21 | Atorvastatin 20MG | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 63 63 💬
|
22 | Atorvastatin 40 MG oral tablet + N-acetylcysteine 400 MG oral tablet | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 63 63 💬
|
23 | Atra | 1件: Tretinoin Tretinoin | 1件: Tretinoin
Tretinoin
💬
| 3件: PML PML, RARA, RARB 💬
| 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 2件: 63 63, 94 💬
|
24 | Avatrombopag | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 2件: 60 60, 63 💬
|
25 | Avatrombopag maleate | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
26 | Avatrombopag tablets | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
27 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 22件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
|
28 | B02bx05 | - | - | - | - | 1件: 63 63 💬
|
29 | Belimumab | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 95, 222, 296 💬
|
30 | BI 655064 | - | - | - | - | 2件: 46 46, 63 💬
|
31 | Biological: M254 | - | - | - | - | 1件: 63 63 💬
|
32 | Blisibimod | 1件: Blisibimod Blisibimod | 1件: Blisibimod
Blisibimod
💬
| - | - | 5件: 43 43, 44, 49, 63, 66 💬
|
33 | BMS-986004 | - | - | - | - | 1件: 63 63 💬
|
34 | BMS-986004 1500 MG IV | - | - | - | - | 1件: 63 63 💬
|
35 | BMS-986004 225 MG IV | - | - | - | - | 1件: 63 63 💬
|
36 | BMS-986004 675 MG IV | - | - | - | - | 1件: 63 63 💬
|
37 | BMS-986004 75 MG IV | - | - | - | - | 1件: 63 63 💬
|
38 | Bortezomib | 2件: Bortezomib Bortezomib, Bortezomib D-mannitol | 1件: Bortezomib
Bortezomib
💬
| 1件: PSMB5 PSMB5 💬
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 16件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 172, 222, 228, 256, 288, 331 💬
|
39 | BT595 | - | - | - | - | 2件: 63 63, 65 💬
|
40 | Caffeic acid tablets | - | - | - | - | 1件: 63 63 💬
|
41 | Caplacizumab | 1件: Caplacizumab Caplacizumab | 1件: Caplacizumab
Caplacizumab
💬
| 1件: VWF VWF 💬
| 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 2件: 63 63, 64 💬
|
42 | CAR-T cells | - | - | - | - | 1件: 63 63 💬
|
43 | CC312 | - | - | - | - | 5件: 46 46, 49, 51, 61, 63 💬
|
44 | CD4-IGG | - | - | - | - | 1件: 63 63 💬
|
45 | Clarithromycin | 1件: Clarithromycin Clarithromycin | 1件: Clarithromycin
Clarithromycin
💬
| - | - | 8件: 6 6, 46, 63, 84, 96, 97, 228, 299 💬
|
46 | CM313 injection | - | - | - | - | 3件: 35 35, 49, 63 💬
|
47 | CM336 injection | - | - | - | - | 1件: 63 63 💬
|
48 | Collection OF biological samples | - | - | - | - | 1件: 63 63 💬
|
49 | Combination OF rituximab with subcutaneous belimumab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬
|
50 | Conventional | - | - | - | - | 1件: 63 63 💬
|
51 | Corticosteroids | - | - | - | - | 12件: 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬
|
52 | Corticosteroids combined with immunoglobulin and romiplostim | - | - | - | - | 1件: 63 63 💬
|
53 | CSA | - | - | - | - | 5件: 19 19, 49, 60, 63, 222 💬
|
54 | Cyclosporin | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 50 50, 54, 60, 63, 97, 107, 222, 274, 326 💬
|
55 | Cyclosporine | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 28件: 11 11, 28, 40, 41, 42, 45, 46, 49, 50, 53, 56, 60, 61, 62, 63, 64, 65, 97, 107, 162, 164, 222, 226, 228, 283, 284, 285, 302 💬
|
56 | Danazol | 1件: Danazol Danazol | 1件: Danazol
Danazol
💬
| 3件: AR AR, ESR1, PGR 💬
| 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 5件: 60 60, 63, 64, 65, 285 💬
|
57 | Daratumumab | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 7件: 13 13, 28, 46, 48, 49, 60, 63 💬
|
58 | Daratumumab injection | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 4件: 16 16, 28, 49, 63 💬
|
59 | Darzalex | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 3件: 28 28, 49, 63 💬
|
60 | Decitabine | 1件: Decitabine Decitabine | 1件: Decitabine
Decitabine
💬
| 3件: DNMT1 DNMT1, DNMT3A, DNMT3B 💬
| 3件: Cysteine and methionine metabolism Cysteine and methionine metabolism, Efferocytosis, MicroRNAs in cancer 💬 | 2件: 60 60, 63 💬
|
61 | Desametasone 40MG | - | - | - | - | 1件: 63 63 💬
|
62 | Dexamethasone | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 22件: 13 13, 14, 16, 19, 28, 35, 63, 64, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
|
63 | Dexamethasone abcur | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
64 | Dexamethasone and rituximab | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
65 | Dexamethasone combined with romiplostim N01 | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
66 | Dexamethasone monotherapy | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
67 | Dexamethasone oral | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
68 | Dexamethasone palmitate | 2件: Dexamethasone Dexamethasone, Dexamethasone palmitate | 4件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone palmitate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
69 | Dexamethasone USP micronized | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
70 | Diammonium glycyrrhizinate enteric-coated capsule | - | - | - | - | 1件: 63 63 💬
|
71 | Difenidramina cloridrato | - | - | - | - | 3件: 11 11, 19, 63 💬
|
72 | Doptelet 20 MG FILM-coated tablets | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
73 | Doxil | - | - | - | - | 1件: 63 63 💬
|
74 | Dyphenhydramine hydrochloride | - | - | - | - | 1件: 63 63 💬
|
75 | E5501 | - | - | - | - | 1件: 63 63 💬
|
76 | E5501 40 MG 2 X 20-MG tablets, orally, fasted | - | - | - | - | 1件: 63 63 💬
|
77 | E5501 40 MG 2 X 20-MG tablets, orally, with food | - | - | - | - | 1件: 63 63 💬
|
78 | E5501 40MG 2 X 20-MG tablets, orally, fasted | - | - | - | - | 1件: 63 63 💬
|
79 | Efgartigimod | - | - | - | - | 6件: 11 11, 14, 35, 53, 63, 64 💬
|
80 | Efgartigimod alfa | 1件: Efgartigimod alfa Efgartigimod alfa | 1件: Efgartigimod alfa
Efgartigimod alfa
💬
| - | - | 6件: 11 11, 14, 35, 53, 63, 162 💬
|
81 | Efgartigimod alpha | - | - | - | - | 1件: 63 63 💬
|
82 | Efgartigimod IV | - | - | - | - | 3件: 11 11, 63, 222 💬
|
83 | Efgartigimod PH20 SC | - | - | - | - | 5件: 11 11, 14, 35, 63, 162 💬
|
84 | Eltrombopag | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 5件: 60 60, 63, 65, 284, 285 💬
|
85 | Eltrombopag 25 MG | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 2件: 60 60, 63 💬
|
86 | Eltrombopag and dexamethasone | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
87 | Eltrombopag and romiplastim | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
88 | Eltrombopag combining rituximab | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
89 | Eltrombopag olamine | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 2件: 60 60, 63 💬
|
90 | Eltrombopag olamine, revolade, promacta | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
91 | Eltrombopag oral tablets | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
92 | Eltrombopag plus diacerein | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
93 | ESG206 | - | - | - | - | 1件: 63 63 💬
|
94 | Estimation OF serum level OF IL17 | - | - | - | - | 1件: 63 63 💬
|
95 | Estimation OF serum level OF IL2 | - | - | - | - | 1件: 63 63 💬
|
96 | Ethanolamine | 1件: Ethanolamine Ethanolamine | 1件: Monoethanolamine
Monoethanolamine
💬
| - | - | 1件: 63 63 💬
|
97 | Fecal microbiota transplantation | 1件: Fecal microbiota Fecal microbiota | - | - | - | 10件: 2 2, 6, 13, 63, 66, 94, 96, 97, 99, 271 💬
|
98 | Fostamatinib | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 3件: 46 46, 49, 63 💬
|
99 | Fostamatinib disodium | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 4件: 46 46, 61, 63, 66 💬
|
100 | Fostamatinib disodium / R935788 | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 63 63 💬
|
101 | Fostamatinib disodium 100 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 63 63 💬
|
102 | Fostamatinib disodium 150 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 63 63 💬
|
103 | Fostamatinib disodium tablets | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 63 63 💬
|
104 | Gammaplex | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 2件: 63 63, 65 💬
|
105 | Gammaplex, intravenous immunoglobulin | - | - | - | - | 1件: 63 63 💬
|
106 | Global DNA methylation will BE quantified IN THE DNA samples BY colorimetry | - | - | - | - | 1件: 63 63 💬
|
107 | Glycyrrhetinic acid | - | - | - | - | 1件: 63 63 💬
|
108 | Glycyrrhiza | 1件: Glycyrrhiza glabra Glycyrrhiza glabra | - | - | - | 2件: 53 53, 63 💬
|
109 | GMA161 | - | - | - | - | 1件: 63 63 💬
|
110 | GNR-069 | - | - | - | - | 1件: 63 63 💬
|
111 | H. pylori triple therapy | - | - | - | - | 1件: 63 63 💬
|
112 | HBM9161 dose A | - | - | - | - | 1件: 63 63 💬
|
113 | HBM9161 dose B | - | - | - | - | 1件: 63 63 💬
|
114 | Healthy controls | - | - | - | - | 1件: 63 63 💬
|
115 | Herombopag | - | - | - | - | 2件: 60 60, 63 💬
|
116 | Herombopag olamine tablets | - | - | - | - | 1件: 63 63 💬
|
117 | Hetrombopag | 1件: Hetrombopag Hetrombopag | - | - | - | 2件: 60 60, 63 💬
|
118 | Hetrombopag 5MG PO QD | 1件: Hetrombopag Hetrombopag | - | - | - | 1件: 63 63 💬
|
119 | Hetrombopag olamine | 1件: Hetrombopag Hetrombopag | - | - | - | 2件: 60 60, 63 💬
|
120 | High dose dexamethasone pulses | - | - | - | - | 1件: 63 63 💬
|
121 | HIGH-dose dexamethasone | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
122 | Higher dose OF rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬
|
123 | HMPL-523 | - | - | - | - | 2件: 46 46, 63 💬
|
124 | Huaiqihuang granule | - | - | - | - | 2件: 63 63, 222 💬
|
125 | Human immunoglobulin | - | - | - | - | 2件: 63 63, 65 💬
|
126 | Human immunoglobulin G | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 3件: 14 14, 50, 63 💬
|
127 | Human normal immunoglobulin | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 8件: 11 11, 13, 14, 43, 45, 50, 63, 65 💬
|
128 | Human normal immunoglobulin FOR intravenous USE | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 2件: 63 63, 65 💬
|
129 | Human normal immunoglobulin FOR intrvenous USE | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 1件: 63 63 💬
|
130 | Humax-CD38 | - | - | - | - | 2件: 28 28, 63 💬
|
131 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 26件: 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
|
132 | Hydroxychloroquine oral tablet | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 2件: 63 63, 66 💬
|
133 | Hypersialylated immunoglobulin | - | - | - | - | 1件: 63 63 💬
|
134 | I10E | - | - | - | - | 3件: 14 14, 63, 65 💬
|
135 | Ianalumab | 1件: Ianalumab Ianalumab | 1件: Ianalumab
Ianalumab
💬
| 1件: TNFRSF13C TNFRSF13C 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬 | 8件: 35 35, 46, 49, 51, 53, 61, 63, 95 💬
|
136 | IG vena 100 ML vial | - | - | - | - | 1件: 63 63 💬
|
137 | IG vena 50 G/L solution FOR infusion 100 ML vial + infusion SET | - | - | - | - | 2件: 63 63, 65 💬
|
138 | IGG next generation | - | - | - | - | 2件: 63 63, 65 💬
|
139 | IGIV3I grifols | - | - | - | - | 1件: 63 63 💬
|
140 | Igpro10 | - | - | - | - | 4件: 14 14, 51, 63, 65 💬
|
141 | Immune globulin intravenous | - | - | - | - | 2件: 63 63, 65 💬
|
142 | Immune globulin intravenous (human), 10% triple virally reduced solution | - | - | - | - | 1件: 63 63 💬
|
143 | Immunglobulin | - | - | - | - | 1件: 63 63 💬
|
144 | Immunoglobulin | - | - | - | - | 3件: 13 13, 14, 63 💬
|
145 | Immunoglobulin G | - | - | - | - | 9件: 2 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
|
146 | Immunoglobulina umana normale | - | - | - | - | 3件: 51 51, 63, 65 💬
|
147 | Inactivated trivalent influenza vaccine | - | - | - | - | 1件: 63 63 💬
|
148 | Interleukin 2 | - | - | - | - | 11件: 35 35, 46, 49, 51, 56, 63, 95, 96, 97, 162, 271 💬
|
149 | Intravenous immunoglobulin (ivig), 10% solution FOR infusion | - | - | - | - | 1件: 63 63 💬
|
150 | Ivig | - | - | - | - | 8件: 11 11, 13, 14, 35, 51, 63, 65, 172 💬
|
151 | Ivig infusion | - | - | - | - | 1件: 63 63 💬
|
152 | IVIG-L | - | - | - | - | 1件: 63 63 💬
|
153 | L01fc01 | - | - | - | - | 1件: 63 63 💬
|
154 | Lansoprazole, clarithromycin, amoxycillin | 1件: Lansoprazole Lansoprazole | 1件: Lansoprazole
Lansoprazole
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 63 63 💬
|
155 | LGD-4665 | - | - | - | - | 1件: 63 63 💬
|
156 | LIV-gamma SN INJ. | - | - | - | - | 1件: 63 63 💬
|
157 | Lusutrombopag | 1件: Lusutrombopag Lusutrombopag | 1件: Lusutrombopag
Lusutrombopag
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 2件: 60 60, 63 💬
|
158 | Lusutrombopag oral tablet | 1件: Lusutrombopag Lusutrombopag | 1件: Lusutrombopag
Lusutrombopag
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
159 | M254 | - | - | - | - | 1件: 63 63 💬
|
160 | Mabthera | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 17件: 11 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 61, 63, 64, 65, 83, 162, 222 💬
|
161 | MabthéRA | - | - | - | - | 3件: 35 35, 63, 162 💬
|
162 | Medical standard OF care FOR ITP | - | - | - | - | 1件: 63 63 💬
|
163 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
164 | Methylprednisolone and ivig | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
165 | Metilprednisolone | - | - | - | - | 2件: 11 11, 63 💬
|
166 | Metronidazole | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | 7件: 46 46, 51, 63, 94, 96, 97, 291 💬
|
167 | Mezagitamab | 1件: Mezagitamab Mezagitamab | 1件: Mezagitamab
Mezagitamab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 2件: 63 63, 66 💬
|
168 | Montelukast | 1件: Montelukast Montelukast | 2件: Montelukast sodium
Montelukast sodium
,
Montelukast
💬
| 1件: CYSLTR1 CYSLTR1 💬
| 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 9件: 6 6, 13, 19, 46, 61, 63, 85, 98, 228 💬
|
169 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 32件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
|
170 | Nanogam | - | - | - | - | 1件: 63 63 💬
|
171 | Neofordex | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
172 | Newgam | - | - | - | - | 3件: 14 14, 63, 65 💬
|
173 | Nicotinamide adenine dinucleotid/nicotinamide mononucleotide | 1件: Nicotinamide Nicotinamide | 1件: Niacinamide
Niacinamide
💬
| - | - | 1件: 63 63 💬
|
174 | NK cells | 1件: Natural Killer Cell Natural Killer Cell | - | - | - | 3件: 26 26, 49, 63 💬
|
175 | Nplate | 1件: Romiplostim Romiplostim | 1件: Romiplostim
Romiplostim
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 2件: 60 60, 63 💬
|
176 | Nplate 500 microgramos polvo para solucióN inyectable | 1件: Romiplostim Romiplostim | 1件: Romiplostim
Romiplostim
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
177 | Obinutuzumab | 1件: Obinutuzumab Obinutuzumab | 1件: Obinutuzumab
Obinutuzumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 5件: 43 43, 44, 49, 63, 222 💬
|
178 | Orelabrutinib | 1件: Orelabrutinib Orelabrutinib | 1件: Orelabrutinib
Orelabrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 4件: 13 13, 49, 61, 63 💬
|
179 | Paracetamolo | - | - | - | - | 7件: 2 2, 11, 14, 28, 61, 63, 309 💬
|
180 | PF-06755347 intravenous healthy participant | - | - | - | - | 1件: 63 63 💬
|
181 | PF-06755347 subcutaneous healthy participant | - | - | - | - | 1件: 63 63 💬
|
182 | PF-06755347 subcutaneous ITP | - | - | - | - | 1件: 63 63 💬
|
183 | PF-06835375 | - | - | - | - | 3件: 46 46, 49, 63 💬
|
184 | PG2 | - | - | - | - | 1件: 63 63 💬
|
185 | Plasma RNA isolation, qpcr analysis OF micro RNA | - | - | - | - | 1件: 63 63 💬
|
186 | PN20 | - | - | - | - | 1件: 63 63 💬
|
187 | PN20 treatment | - | - | - | - | 1件: 63 63 💬
|
188 | Povetacicept | 1件: Povetacicept Povetacicept | 1件: Povetacicept
Povetacicept
💬
| 1件: TNFRSF13B TNFRSF13B 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Primary immunodeficiency 💬 | 3件: 61 61, 63, 222 💬
|
189 | Prednisolone | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 38件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
190 | Prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 54件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
191 | Prednisone acetate | 2件: Prednisone Prednisone, Prednisone acetate | 2件: Prednisone
Prednisone
,
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 6件: 35 35, 46, 49, 63, 162, 222 💬
|
192 | Prednisone tablet | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
193 | Privigen | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 5件: 11 11, 14, 51, 63, 65 💬
|
194 | PRN1008 | - | - | - | - | 4件: 35 35, 61, 63, 300 💬
|
195 | PRN1008 100 MG tablet | - | - | - | - | 1件: 63 63 💬
|
196 | PRN1008 300 MG tablet | - | - | - | - | 1件: 63 63 💬
|
197 | PRN1008 400 MG tablet | - | - | - | - | 1件: 63 63 💬
|
198 | ProteíNA recombinante estimulante DE LA megacariopoyesis | - | - | - | - | 1件: 63 63 💬
|
199 | Proton pump inhibitor 1 MG/KG/DAY IN 2 divided doses 1 month | - | - | - | - | 1件: 63 63 💬
|
200 | PRTX-100 | 1件: PRTX-100 PRTX-100 | - | - | - | 2件: 46 46, 63 💬
|
201 | QL0911 | - | - | - | - | 1件: 63 63 💬
|
202 | Quality-OF-life assessment | - | - | - | - | 11件: 28 28, 34, 36, 51, 62, 63, 65, 96, 284, 286, 298 💬
|
203 | R788 | - | - | - | - | 2件: 46 46, 63 💬
|
204 | R935788 | - | - | - | - | 4件: 46 46, 61, 63, 66 💬
|
205 | Rapamycin | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 19件: 2 2, 15, 34, 35, 46, 49, 51, 53, 60, 61, 63, 67, 86, 96, 158, 193, 256, 279, 283 💬
|
206 | Recombinant human thrombopoietin | 1件: Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin | - | - | - | 1件: 63 63 💬
|
207 | Relovade | - | - | - | - | 1件: 63 63 💬
|
208 | Revolade | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 2件: 60 60, 63 💬
|
209 | Revolade 25 MG FILM-coated tablets | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
210 | Revolade 50 MG FILM-coated tablets | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
211 | Revolade, promacta | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
212 | Rhtpo | 1件: Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin | - | - | - | 2件: 60 60, 63 💬
|
213 | Rhtpo IN combination with rituximab | 1件: Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin | - | - | - | 1件: 63 63 💬
|
214 | Rilzabrutinib | 1件: Rilzabrutinib Rilzabrutinib | 1件: Rilzabrutinib
Rilzabrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 5件: 35 35, 61, 63, 222, 300 💬
|
215 | Rituxan | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 7件: 35 35, 46, 60, 61, 63, 256, 288 💬
|
216 | Rituxan, cyclophosphamide, vincristine, prednisone | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬
|
217 | Rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 52件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
218 | Rituximab and dexamethasone | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬
|
219 | Romiplostim | 1件: Romiplostim Romiplostim | 1件: Romiplostim
Romiplostim
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 4件: 60 60, 63, 64, 65 💬
|
220 | Romiplostim plus dexamethasone | 2件: Dexamethasone Dexamethasone, Romiplostim | 4件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
,
Romiplostim
💬
| 2件: NR3C1 NR3C1, TPOR 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
221 | Romiplostin | - | - | - | - | 1件: 63 63 💬
|
222 | Rozanolixizumab | 1件: Rozanolixizumab Rozanolixizumab | 1件: Rozanolixizumab
Rozanolixizumab
💬
| - | - | 3件: 11 11, 14, 63 💬
|
223 | SAR444671 | - | - | - | - | 3件: 61 61, 63, 300 💬
|
224 | SB-497115 | - | - | - | - | 1件: 63 63 💬
|
225 | SB-497115-GR | - | - | - | - | 1件: 63 63 💬
|
226 | SB-497115-GR 12.5MG | - | - | - | - | 1件: 63 63 💬
|
227 | SB-497115-GR 25MG | - | - | - | - | 1件: 63 63 💬
|
228 | SB-497115-GR 50 MG | - | - | - | - | 1件: 63 63 💬
|
229 | SB497115 | - | - | - | - | 2件: 60 60, 63 💬
|
230 | Serum interleukin 10 level | - | - | - | - | 1件: 63 63 💬
|
231 | Sirolimus | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 39件: 6 6, 13, 15, 19, 21, 34, 35, 36, 46, 48, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 97, 98, 137, 157, 158, 192, 222, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
232 | SM101 | - | - | - | - | 3件: 49 49, 63, 66 💬
|
233 | SM101 20MG/ML | - | - | - | - | 1件: 63 63 💬
|
234 | SM101 5MG/ML | - | - | - | - | 1件: 63 63 💬
|
235 | Standard therapy (without eltrombopag): HD-DXM | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
236 | Staphylococcal protein A | 1件: Bevifimod Bevifimod | - | - | - | 1件: 63 63 💬
|
237 | Steroids | - | - | - | - | 6件: 46 46, 50, 51, 63, 96, 97 💬
|
238 | STSA-1301 subcutaneous injection | - | - | - | - | 1件: 63 63 💬
|
239 | SYM001 | - | - | - | - | 1件: 63 63 💬
|
240 | TAK-079 | - | - | - | - | 3件: 11 11, 49, 63 💬
|
241 | Telitacicept | 1件: Telitacicept Telitacicept | - | - | - | 11件: 11 11, 13, 46, 48, 49, 51, 53, 63, 66, 222, 300 💬
|
242 | Teriflunomide | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 4件: 13 13, 25, 26, 63 💬
|
243 | Thrombopoietin | 1件: Thrombopoietin Thrombopoietin | - | - | - | 2件: 47 47, 63 💬
|
244 | TPO | - | - | - | - | 1件: 63 63 💬
|
245 | TPO-RA | - | - | - | - | 1件: 63 63 💬
|
246 | TPO-RAS combining ANTI-CD 20 monoclonal antibody | - | - | - | - | 1件: 63 63 💬
|
247 | TQB3473 tablets | - | - | - | - | 1件: 63 63 💬
|
248 | Treatment : H. pylori eradication | - | - | - | - | 1件: 63 63 💬
|
249 | Tretinoin | 1件: Tretinoin Tretinoin | 1件: Tretinoin
Tretinoin
💬
| 3件: PML PML, RARA, RARB 💬
| 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 3件: 62 62, 63, 75 💬
|
250 | Triple therapy | - | - | - | - | 2件: 50 50, 63 💬
|
251 | Tysabri | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 3件: 13 13, 25, 63 💬
|
252 | UCB7665 | 1件: Rozanolixizumab Rozanolixizumab | 1件: Rozanolixizumab
Rozanolixizumab
💬
| - | - | 3件: 11 11, 14, 63 💬
|
253 | VAY736 | - | - | - | - | 9件: 13 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
|
254 | Veltuzumab | 1件: Veltuzumab Veltuzumab | 1件: Veltuzumab
Veltuzumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 46 46, 63 💬
|
255 | Vinblastine | 1件: Vinblastine Vinblastine | 2件: Vinblastine sulfate
Vinblastine sulfate
,
Vinblastine
💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 2件: 34 34, 63 💬
|
256 | VIT D | - | - | - | - | 2件: 63 63, 227 💬
|
257 | VON willebrand factor | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 2件: 63 63, 288 💬
|
258 | Vonoprazan | 1件: Vonoprazan Vonoprazan | 1件: Vonoprazan
Vonoprazan
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 3件: 63 63, 97, 98 💬
|
259 | Water | 1件: Water Water | 1件: Water
Water
💬
| - | - | 25件: 2 2, 5, 6, 13, 17, 19, 22, 46, 51, 53, 56, 57, 63, 64, 66, 67, 85, 96, 97, 206, 226, 230, 274, 278, 299 💬
|
260 | Zanubrutinib | 1件: Zanubrutinib Zanubrutinib | 1件: Zanubrutinib
Zanubrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 5件: 13 13, 61, 63, 222, 331 💬
|
261 | Zuberitamab | 1件: ZUBERITAMAB ZUBERITAMAB | - | - | - | 1件: 63 63 💬
|